SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-278392
Filing Date
2021-09-21
Accepted
2021-09-21 17:03:54
Documents
1
Group Members
ALPINE BIOVENTURES, GP, LLCJAY VENKATESANMITCHELL H. GOLD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d217957dsc13da.htm SC 13D/A 157833
  Complete submission text file 0001193125-21-278392.txt   159646
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88896 | Film No.: 211267097
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101
Business Address 600 STEWART STREET SUITE 1503 SEATTLE WA 98101 206-441-5064
Alpine ImmunoSciences, L.P. (Filed by) CIK: 0001628571 (see all company filings)

IRS No.: 472413265 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A